Donald Trump Claims Credit for Record Prescription Drug Price Drop

President Donald Trump and the White House claimed credit for a 3.1% year-over-year decline in prescription drug prices as of July 2026, the steepest annual drop since 1963. During a photo-op, Trump displayed a Washington Post headline reporting the decline, stating, "I told you that was going to happen." The administration attributes the savings to the TrumpRx discount platform, which it claims saved patients $700 million, and "most favored nation" policies established by Executive Order 14297 to align U.S. prices with other developed nations.

White House officials highlighted deals with pharmaceutical companies like Pfizer, Eli Lilly, and Novo Nordisk to cut cash prices for GLP-1 medications. However, independent experts and economists argue the decline was primarily driven by the 2022 Inflation Reduction Act enacted under former President Joe Biden, which allowed Medicare to negotiate prices for high-cost drugs. Other contributing factors include increased competition from generics and biosimilars.

Administration spokesperson Kush Desai dismissed the link to the Inflation Reduction Act as "idiotic and unfounded." Meanwhile, Senator Elizabeth Warren questioned the reliability of the administration's $700 million savings claim, noting that Health Secretary Robert F. Kennedy Jr. admitted the TrumpRx site does not store patient or prescription data. Analysts also noted that while the Consumer Price Index showed a decline in pharmacy payments, other healthcare costs, such as hospital services, rose by 5.2%.